Nihon Medi-Physics Receives Manufacturing Approval For PET Radiopharmaceutical FDG Scan Injection

Tokyo (JCN) - Nihon Medi-Physics announced on July 27 that it has received approval to manufacture FDG Scan Injection (fludeoxyglucose F-18), its proprietary radiopharmaceutical used in positron emission tomography (PET), from the Ministry of Health, Labor and Welfare. The new agent is the first PET agent that has been approved in Japan.

Back to news